Bolt Biotherapeutics: enters second lease amendment, pays $1,000,000

What happened

• On Oct 1, 2026, Bolt Biotherapeutics, Inc. entered into the Second Amendment to Lease with HCP LS Redwood City LLC relating to the company’s corporate office, laboratory and vivarium facilities at 800 and 900 Chesapeake Drive, Redwood City, California.
• Pursuant to the Second Lease Amendment, the company paid the landlord $1,000,000 and acknowledged, and agreed, that the landlord has the right to draw the existing $1,500,000 letter of credit in its entirety. The parties agreed to an accelerated lease expiration date of Dec 31, 2027, or earlier following the closing of a financing or other strategic transaction of the company (a "Corporate Transaction").

Key details

• The Second Lease Amendment provides that, upon the closing of a Corporate Transaction, the company will pay the landlord an additional $4,500,000 termination payment (the "Termination Payment").
• Effective Oct 1, 2026, the filing states the company's ongoing rent and operating expense obligations for the premises are not significant.
• The company will continue its existing sublease arrangements for portions of the 800 Building and will remit to the landlord 100% of the sublease rent and common area maintenance payments received from each subtenant.
• The company is evaluating the accounting effects of the Second Lease Amendment. The lease amended a lease dated Aug 7, 2020, as previously amended.

Why it may matter

• This filing reports Item 1.01 (entry into a material definitive agreement), covering a second amendment to the company's lease for its Redwood City office, lab and vivarium facilities.
• The filing does not show why the company acted.